{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "79278",
      "recalling_firm": "Akorn, Inc.",
      "address_1": "1925 W Field Ct Ste 300",
      "address_2": "N/A",
      "postal_code": "60045-4862",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0577-2018",
      "product_description": "Atropine Sulfate Ophthalmic 1% Solution, USP, 5mL per bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  NDC: 17478-215-05",
      "product_quantity": "31,812 bottles",
      "reason_for_recall": "Failed Stability Specification: OOS low viscosity results discovered during retain testing.",
      "recall_initiation_date": "20180221",
      "center_classification_date": "20180305",
      "termination_date": "20200831",
      "report_date": "20180314",
      "code_info": "Lot: 011037A"
    }
  ]
}